Good morning, everyone, and how are you today? We are doing just fine, thank you, despite unusually blustery winds whipping through the Pharmalot campus. A quick peek out the nearby portal offers an interesting view of a few fallen tree branches nearby, a gazillion acorns, and some detritus along the street, too. But things will calm down soon enough. So why not join us for a cup of stimulation or three? We are favoring coconut this morning, for no particular reason. Meanwhile, here are a few items of interest to help you along. Hope you conquer the world today and, as always, do keep in touch …

Two drug makers and the nation’s three largest distributors are offering $22 billion in cash as well as medicines and services they value at $28 billion to resolve lawsuits alleging the industry fueled the U.S. opioid crisis, Reuters reports. McKesson (MCK), Cardinal Health (CAH), and AmerisourceBergen (ABC) offered to pay $18 billion in cash over 18 years, while Johnson & Johnson (JNJ) would pay $4 billion in cash, and Teva Pharmaceutical (TEVA) offered to give away medicines it values at $15 billion and provide distribution services valued in the billions.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!

GET STARTED

What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • Online intelligence briefings
  • Frequent opportunities to engage with veteran beat reporters and industry experts
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Leave a Comment

Please enter your name.
Please enter a comment.